Jeremy Weleff

Oct 4, 2024 | onlinelibrary.wiley.com | Jeremy Weleff |Nicholaus Christian |James Wang |Mohit Singh

INTRODUCTION The US drug overdose epidemic reached a grim milestone in 2021 with over 100,000 fatalities, highlighting the urgency to adapt clinical practices to the evolving threat posed by fentanyl and other high-potency synthetic opioids (HPSOs).1, 2 In this context, there have been many calls to action to address the regulations surrounding the use of medications for opioid use disorder (MOUD) and improve access to these life-saving medications.3, 4 During the COVID-19 pandemic, the USA...

Apr 16, 2024 | bpspubs.onlinelibrary.wiley.com | Jeremy Weleff |Julio C Nunes |Mehmet Sofuoglu |R. Ross MacLean

CONFLICT OF INTEREST STATEMENT The authors disclose no conflicts of interest. J.P.D. has been supported in clinical trials by Jazz Pharmaceuticals, specifically through medication provisions. Additionally, J.P.D. has been a compensated consultant for Boehringer Ingelheim. REFERENCES 1, , . Drug overdose deaths in the United States, 2001-2021. NCHS Data Brief. 2022; 457: 1-8. 2. The triple wave epidemic: supply and demand drivers of the US opioid overdose crisis. Int J Drug Policy.